Table 3 Comparison between mild, moderate, and severe SLE patients regarding demographic, anthropometric and laboratory findings
Variables | Mild (n = 7) | Moderate (n = 18) | Severe (N = 15) | p-value | |
|---|---|---|---|---|---|
Age (years), N (%) | 11.8 ± 1.0 | 11.3 ± 2.4 | 11.5 ± 2.1 | ^0.838 | |
Sex, N (%) | Male | 2 (28.6%) | 1 (5.6%) | 3 (20.0%) | § 0.243 |
Female | 5 (71.4%) | 17 (94.4%) | 12 (80.0%) | ||
Consanguinity, N (%) | 1 (14.3%) | 8 (44.4%) | 5 (33.3%) | § 0.463 | |
Family history of SLE, N (%) | 1 (14.3%) | 4 (22.2%) | 0 (0.0%) | § 0.135 | |
Weight (SDS), mean ± SD | -0.4 ± 0.6 | -0.3 ± 1.0 | -0.2 ± 1.3 | ^0.910 | |
Height (SDS), mean ± SD | -0.3 ± 0.7 | -0.2 ± 1.2 | -0.2 ± 1.0 | ^0.965 | |
BMI (SDS), mean ± SD | -0.2 ± 1.4 | -0.3 ± 0.7 | -0.2 ± 1.2 | ^0.941 | |
Hypertension, N (%) | 6 (85.7%) | 13 (72.2%) | 12 (80.0%) | § 0.786 | |
Puberty features, N (%) | 2 (28.6%) | 11 (61.1%) | 9 (60.0%) | § 0.371 | |
Platelets (x103/mL), mean ± SD | 286.1 ± 103.6 | 312.7 ± 102.2 | 265.8 ± 98.1 | ^0.419 | |
ESR (mm/hr), mean ± SD | 42.4 ± 17.2 | 33.9 ± 28.5 | 44.5 ± 29.2 | ^0.518 | |
C3 (mg/dl), mean ± SD | 58.1 ± 17.0 | 114.2 ± 65.6 | 95.6 ± 71.9 | ^0.149 | |
C4 (mg/dl), mean ± SD | 17.7 ± 18.1 | 20.4 ± 20.5 | 25.9 ± 26.6 | ^0.679 | |
Positive ADNA, N (%) | 4 (57.1%) | 12 (66.7%) | 14 (93.3%) | § 0.073 | |
Positive ANA, N (%) | 6 (85.7%) | 18 (100.0%) | 14 (93.3%) | § 0.296 | |
Prolactin (µg/L), mean ± SD | 14.0 ± 6.2 | 17.0 ± 5.3 | 19.3 ± 7.7 | ^0.212 | |